Eugia Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EUGIA PHARMA, and what generic alternatives to EUGIA PHARMA drugs are available?
EUGIA PHARMA has one hundred and sixty-nine approved drugs.
There is one US patent protecting EUGIA PHARMA drugs. There are three tentative approvals on EUGIA PHARMA drugs.
There are ten patent family members on EUGIA PHARMA drugs in nine countries and three hundred and fifty supplementary protection certificates in eighteen countries.
Summary for Eugia Pharma
| International Patents: | 10 |
| US Patents: | 1 |
| Tradenames: | 143 |
| Ingredients: | 135 |
| NDAs: | 169 |
| Patent Litigation for Eugia Pharma: | See patent lawsuits for Eugia Pharma |
Drugs and US Patents for Eugia Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eugia Pharma | PROGESTERONE | progesterone | INJECTABLE;INJECTION | 210965-001 | Dec 6, 2018 | AO | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Eugia Pharma | VANCOMYCIN HYDROCHLORIDE | vancomycin hydrochloride | POWDER;INTRAVENOUS | 217401-002 | Aug 4, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Eugia Pharma | DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 214575-003 | Jun 25, 2021 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Eugia Pharma | CISATRACURIUM BESYLATE | cisatracurium besylate | INJECTABLE;INJECTION | 209144-001 | May 8, 2020 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Eugia Pharma | SUCCINYLCHOLINE CHLORIDE | succinylcholine chloride | INJECTABLE;INJECTION | 217808-001 | Oct 16, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Eugia Pharma Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Brazil | 112016026140 | ⤷ Try a Trial |
| European Patent Office | 3139929 | ⤷ Try a Trial |
| Japan | 6516831 | ⤷ Try a Trial |
| Canada | 2948148 | ⤷ Try a Trial |
| Australia | 2015256331 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Eugia Pharma Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0564409 | C00564409/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: IMATINIB; REGISTRATION NO/DATE: IKS 55807 20010621 |
| 0717738 | SPC/GB01/025 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: LINEZOLID; REGISTERED: UK PL 00032/0259 20010105; UK PL 00032/0260 20010105; UK PL 00032/0261 20010105; UK PL 00032/0262 20010105 |
| 0206283 | 98C0041 | Belgium | ⤷ Try a Trial | PRODUCT NAME: LEVOFLOXACINUM HEMIHYDRICUM; NAT. REGISTRATION NO/DATE: 354 IS 370 F3 19980624; FIRST REGISTRATION: GB 134020011 19970606 |
| 0275821 | SPC/GB01/039 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: ZOLEDRONIC ACID OPTIONALLY IN THE FORM OF A SALT THEREOF; NATIONAL REGISTRATION NO/DATE: EU/1/01/176/001-003 20010320; FIRST REGISTRATION: CH 55463 20001128 |
| 0564409 | 2002/005 | Ireland | ⤷ Try a Trial | PRODUCT NAME: IMATINIB OR ONE OF ITS PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALTS, ESPECIALLY THE MONOMETHANESULFONATE SALT; NAT REGISTRATION NO/DATE: EU/1/01/198/001-006 20011107; FIRST REGISTRATION NO/DATE: CH 55807 55807 01 55807 02 20010621; PAEDIATRIC INVESTIGATION PLAN: P/0028/2012 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
